6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold The FANTOM II Study
6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold The FANTOM II Study
复制标题
DOI：
10.1016/j.jcin.2017.07.033
复制
发表时间：
2017-09-25
影响因子：
11.3
通讯作者：
Stone, Gregg W.
中科院分区：
文献类型：
--
作者：
Abizaid, Alexandre;Carrie, Didier;Stone, Gregg W.
本研究的目的是评价新型幻影冠状动脉生物可吸收支架在6个月后的疗效。背景幻影西罗莫司洗脱生物可吸收支架结合了一种独特的专有的碘化聚碳酸酯酪氨酸类似物共聚物，它是不透射线的，具有薄的支架(125 Mm)，便于装置输送和精确的靶向病变治疗。方法对117例单支新生冠状动脉病变患者进行6个月的疗效和性能评估
OBJECTIVES The purpose of this study was to evaluate the outcomes of the novel Fantom coronary bioresorbable scaffold at 6 months.BACKGROUND The Fantom sirolimus-eluting bioresorbable scaffold incorporates a unique proprietary iodinated, polycarbonate copolymer of tyrosine analogs that is radiopaque, with thin struts (125 mm) that facilitate device delivery and precise target lesion treatment.METHODS The 6-month outcomes and performance of the Fantom scaffold were evaluated in 117 patients with single de novo native coronary artery lesions of length